Hereditary cancer testing—expand patients’ understanding of their risks
Approximately 5% to 10% of all cancers are thought to be caused by mutations in genes associated with hereditary cancer syndromes.1
As your patients learn more about genetic testing during family planning—and the conditions they may carry and pass on—they may have questions and concerns about certain cancers that may run in their families.
This is why we provide hereditary cancer testing options—to extend the continuity of care beyond reproductive health, and ensure that your patients’ questions, concerns, and genetic testing for hereditary cancers can be managed by the same laboratory.
As with every family of tests we offer, Integrated Genetics offers choice in testing options for hereditary cancer, with testing for identifying BRCA mutations associated with breast and ovarian cancer syndrome, as well as broader hereditary cancer panels for genes associated with many different types of cancer.
Patients with BRCA mutations are at increased risk for breast, ovarian, and other cancers. Knowing your patient’s BRCA mutation status may assist in development of tailored prevention and treatment strategies. For this reason, Integrated Genetics offers a suite of BRCAssure tests to meet patients’ varied needs.
VistaSeq is a multi-gene assay for genetic mutations known to be associated with an increased risk of developing hereditary cancers. With 12 test panels, the VistaSeq Hereditary Cancer portfolio helps you give patients more—and more critical—information.
Variant Classification Document
- Family Cancer Syndromes. American Cancer Society website. https://www.cancer.org/cancer/cancer-causes/genetics/family-cancer-syndromes.html. Updated April 19, 2017. Accessed June 28, 2017.